Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT

17 May 2012

Abstract excerpt

To the editor: Allogeneic hematopoietic stem cell transplantation (HSCT) can grant long-term control and cure of acute myeloid leukemia (AML) thanks to the antitumor effect of the transplanted immune system. Still, relapse remains an open issue: in the haploidentical setting, we and others

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22596173
DOI: 10.1182/blood-2012-02-411686

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCTPMID 22596173Read ↗

Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationSemantic proximity Read ↗

Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-LeukemiaSemantic proximity Read ↗

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.Semantic proximity Read ↗

Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantationSemantic proximity Read ↗

Loss of mismatched HLA detected in the peripheral blood of an AML patient who relapsed after haploidentical hematopoietic stem cell transplantation.Semantic proximity Read ↗

Loss of mismatched HLA in leukemia after stem-cell transplantation.Semantic proximity Read ↗

Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.Semantic proximity Read ↗

Immune Escape of Relapsed AML Cells after Allogeneic TransplantationSemantic proximity Read ↗

Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read ↗

Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of RelapseSemantic proximity Read ↗

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.